Brief: Sagimet Biosciences Announces Pricing Of Public Offering Of Series A Common Stock
26/01/2024 01:59
Jan 25 (Reuters) - Sagimet Biosciences Inc SGMT.O :
* SAGIMET BIOSCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING
OF
SERIES A COMMON STOCK
* SAGIMET BIOSCIENCES INC - PRICING OF ITS UNDERWRITTEN
PUBLIC
OFFERING OF 9 MILLION SHARES OF ITS SERIES A COMMON STOCK AT A
PRICE OF $12.50 PER SHARE
Source text for Eikon: ID:nGNX8JJfmw
Further company coverage: SGMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage